{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-022447","form_type":"8-K","ticker":"PRME","cik":"0001894562","company_name":"Prime Medicine, Inc.","filed_at":"2023-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.530571+00:00","generated_at":"2026-06-13T23:20:43.515521+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"high","headline":"Prime Medicine elects Kelly and Schenkein to board, ratifies PwC as auditor","bullets":["Michael Kelly elected Class I director with 64.5M for, 1.3M withheld; David Schenkein with 62.0M for, 3.7M withheld.","Broker non-votes on director election totaled 1,517,331.","PricewaterhouseCoopers LLP ratified as independent auditor for FY2023 with 67.3M for, 6.3K against, 11.5K abstentions.","Annual meeting held June 14, 2023; all proposals approved by stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-022447","json":"https://secwatch.observer/filing/0001628280-23-022447.json","markdown":"https://secwatch.observer/filing/0001628280-23-022447.md","text":"https://secwatch.observer/filing/0001628280-23-022447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894562/000162828023022447/0001628280-23-022447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894562/000162828023022447/prme-20230614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:20:43.515521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"79a7fb66de059b3d2ba7fea7e1b97d5638faf5b0","claim":"Prime Medicine, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-14 meeting.","evidence_excerpt":"The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023 was ratified, based on the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828023022447/0001628280-23-022447-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"ca8e2a944b8de980f3e5372471eda8e6f04af731","claim":"Prime Medicine, Inc. shareholders approved Election of Michael Kelly and David Schenkein as Class I Directors at the 2023-06-14 meeting.","evidence_excerpt":"Each of the following nominees was elected as a Class I Director to serve until the Company’s 2026 annual meeting of stockholders, and until his respective successor shall have been duly elected and qualified, based on the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828023022447/0001628280-23-022447-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}